BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2334936)

  • 1. Effects of interferon on tumor tissue content in liver metastases of human carcinoid tumors.
    Andersson T; Wilander E; Eriksson B; Lindgren PG; Oberg K
    Cancer Res; 1990 Jun; 50(11):3413-5. PubMed ID: 2334936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interferon on T1 relaxation times of liver metastases from endocrine gastrointestinal tumours.
    Andersson T; Eriksson B; Hemmingsson A; Jung B; Lindh E; Thuomas KA; Oberg K
    Acta Radiol; 1988; 29(1):21-5. PubMed ID: 2964840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon treatment in patients with malignant carcinoids.
    Nobin A; Lindblom A; Månsson B; Sundberg M
    Acta Oncol; 1989; 28(3):445-9. PubMed ID: 2742782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-induced nuclear DNA alterations in malignant carcinoid tumors in vivo.
    Wilander E; Bengtsson A; Norheim I; Oberg K
    J Natl Cancer Inst; 1986 Mar; 76(3):429-33. PubMed ID: 2936918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance to long-term treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
    Ahren B; Engman K; Lindblom A
    Anticancer Res; 1992; 12(3):881-4. PubMed ID: 1622146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
    Smith DB; Scarffe JH; Wagstaff J; Johnston RJ
    Cancer Treat Rep; 1987 Dec; 71(12):1265-6. PubMed ID: 3690534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Individual therapeutic procedure in metastatic carcinoid of the small intestine].
    Barthel A; Leonhardt U; Stöckmann F; Ramadori G
    Leber Magen Darm; 1996 May; 26(3):164, 167-9. PubMed ID: 8709831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin in cytologic samples of liver metastases of carcinoid tumors. An immunocytochemical study with a monoclonal antibody.
    Wilander E
    Acta Cytol; 1985; 29(6):1058-60. PubMed ID: 3866458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome.
    Oberg K; Funa K; Alm G
    N Engl J Med; 1983 Jul; 309(3):129-33. PubMed ID: 6191217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hepatic metastasis of gastrointestinal carcinoid tumors.
    Landry CS; Scoggins CR; McMasters KM; Martin RC
    J Surg Oncol; 2008 Mar; 97(3):253-8. PubMed ID: 18264984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.
    Hellman P; Lundström T; Ohrvall U; Eriksson B; Skogseid B; Oberg K; Tiensuu Janson E; Akerström G
    World J Surg; 2002 Aug; 26(8):991-7. PubMed ID: 12016480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.
    Jacobsen MB; Hanssen LE; Kolmannskog F; Schrumpf E; Vatn MH; Bergan A
    Scand J Gastroenterol; 1995 Aug; 30(8):789-96. PubMed ID: 7481548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodine-131-MIBG therapy of a patient with carcinoid liver metastases.
    Prvulovich EM; Stein RC; Bomanji JB; Ledermann JA; Taylor I; Ell PJ
    J Nucl Med; 1998 Oct; 39(10):1743-5. PubMed ID: 9776280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoid tumours and interferon therapy: an undervalued treatment.
    Barrett CA; Smith CH; Slevin ML
    Br J Hosp Med; 1991 Nov; 46(5):339. PubMed ID: 1958937
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultrasound-guided biopsies of neuroendocrine metastases. Comparison of 0.9 and 1.2 mm biopsy-gun needle biopsies.
    Elvin A; Wilander E; Oberg K; Eriksson B; Lindgren PG
    Acta Radiol; 1993 Sep; 34(5):474-7. PubMed ID: 8369183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality treatment for gastric carcinoid tumor with liver metastases.
    Caplin ME; Hodgson HJ; Dhillon AP; Begent R; Buscombe J; Dick R; Rolles K; Burroughs AK
    Am J Gastroenterol; 1998 Oct; 93(10):1945-8. PubMed ID: 9772061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
    Ahren B; Engman K; Lindblom A
    Anticancer Res; 1992; 12(1):129-33. PubMed ID: 1567158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.